CME GROUP INC. Earnings Per Share Disclosure
| (in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| Stock awards | 71 | 89 | 455 | ||||||||||||||
| Total | 71 | 89 | 455 | ||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net Income Attributable to CME Group (in millions) | $ | 4,072.2 | $ | 3,525.8 | $ | 3,226.2 | |||||||||||
| Less: Preferred stock dividends | (22.9) | (47.7) | (44.2) | ||||||||||||||
| Less: (Undistributed earnings) overdistributed earnings allocated to preferred stock | (28.3) | 3.4 | 3.6 | ||||||||||||||
| Net Income Attributable to Common Shareholders of CME Group | $ | 4,021.0 | $ | 3,481.5 | $ | 3,185.6 | |||||||||||
| Weighted Average Common Shares Outstanding (in thousands): | |||||||||||||||||
| Basic | 359,648 | 359,389 | 359,023 | ||||||||||||||
| Effect of stock options and stock awards | 662 | 555 | 477 | ||||||||||||||
| Diluted | 360,310 | 359,944 | 359,500 | ||||||||||||||
| Earnings per Common Share Attributable to Common Shareholders of CME Group: | |||||||||||||||||
| Basic | $ | 11.18 | $ | 9.69 | $ | 8.87 | |||||||||||
| Diluted | 11.16 | 9.67 | 8.86 | ||||||||||||||
Want the next CME GROUP INC. earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment CME GROUP INC.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 26, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.